This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Boutin, H. Articles by Koehler, R. C. Search for Related Content PubMed PubMed Citation Articles by Boutin, H. Articles by Koehler, R. C. Pubmed/NCBI databases Medline Plus Health Information Transient Ischemic Attack

(Stroke. 1999;30:1271-1278.)
© 1999 American Heart Association, Inc.

Original Contributions

Differential Time-Course Decreases in Nonselective, µ-, -, and -Opioid Receptors After Focal Cerebral Ischemia in Mice

Hervé Boutin, PhD; François Dauphin, DPharm, PhD; Eric T. MacKenzie, PhD Philippe Jauzac, MD, DSc

From the University of Caen, CNRS UMR 6551, Centre CYCERON, Caen, France.

Correspondence to F. Dauphin, CNRS UMR 6551, Centre CYCERON, Boulevard H. Becquerel, BP 5229, 14074 Caen Cedex, France. E-mail dauphin{at}cyceron.fr

Background and Purpose—Neuroprotection studies have demonstrated the involvement of opioids in ischemia, and we have previously demonstrated alterations in B_max of opioidergic receptors after 2 post-MCAO time points in mice.

Methods—In the present study, we have investigated in a detailed manner the postischemic time course of variations in [³H]diprenorphine (nonselective), [³H]DAMGO (µ), [³H]DADLE (), and [³H]U69593 () relative binding densities after focal cerebral ischemia (0 to 48 hours) in mice.

Results—In frontoparietal cortices, our results demonstrate decreases in (1) receptor densities at 1 to 3 hours after MCAO, (2) µ and nonselective binding sites at 6 to 12 hours after MCAO, and (3) receptor densities between 6 and 24 hours after MCAO. In the rostral part of the infarct border zone, a decrease in -receptors was found concomitant with the extension of the infarct core; conversely, the decrease in -receptors appeared before (6 to 12 hours) macroscopic histological damage, which occurred between 12 hours and 24 hours after MCAO in the caudal part of this area. In this frontier, µ- and especially -binding sites were decreased later (12 to 48 hours after MCAO).

Conclusions—These differential alterations in opioidergic receptors could be due to the selective sublocalization of receptors, postsynaptically on cortical interneurons for µ- and -receptors versus presynaptically on cortical afferent pathways for the subtype. Further, our results suggest that - and µ-opioidergic receptors could be markers of infarct extension and neuronal death; the study of [³H]diprenorphine and selective binding sites argues in favor of the use of receptor-specific ligands. Finally, the relative preservation of -receptors might be correlated with the neuroprotective role of -agonists, as previously reported.

Editorial Comment

Raymond C. Koehler, PhD, Guest Editor

Anesthesiology/Critical Care Medicine The Johns Hopkins University Baltimore, Maryland

This article has been cited by other articles:

				B. Yulug, E. Cam, A. Yildiz, and E. Kilic Buprenorphine Does Not Aggrevate Ischemic Neuronal Injury in Experimental Focal Cerebral Ischemia J Neuropsychiatry Clin Neurosci, August 1, 2007; 19(3): 331 - 334. [Abstract] [Full Text] [PDF]

				J. Zhang, H. Qian, P. Zhao, S.-S. Hong, and Y. Xia Rapid Hypoxia Preconditioning Protects Cortical Neurons From Glutamate Toxicity Through {delta}-Opioid Receptor Stroke, April 1, 2006; 37(4): 1094 - 1099. [Abstract] [Full Text] [PDF]

				M.-C. Ma, H. Qian, F. Ghassemi, P. Zhao, and Y. Xia Oxygen-sensitive {delta}-Opioid Receptor-regulated Survival and Death Signals: NOVEL INSIGHTS INTO NEURONAL PRECONDITIONING AND PROTECTION J. Biol. Chem., April 22, 2005; 280(16): 16208 - 16218. [Abstract] [Full Text] [PDF]

				T.-Y. Chen, T. Goyagi, T. J.K. Toung, J. R. Kirsch, P. D. Hurn, R. C. Koehler, and A. Bhardwaj Prolonged Opportunity for Ischemic Neuroprotection with Selective {kappa}-Opioid Receptor Agonist in Rats Stroke, May 1, 2004; 35(5): 1180 - 1185. [Abstract] [Full Text] [PDF]

				Z. Zhang, T.-Y. Chen, J. R. Kirsch, T. J. K. Toung, R. J. Traystman, R. C. Koehler, P. D. Hurn, and A. Bhardwaj Kappa-Opioid Receptor Selectivity for Ischemic Neuroprotection with BRL 52537 in Rats Anesth. Analg., December 1, 2003; 97(6): 1776 - 1783. [Abstract] [Full Text] [PDF]

				T. Goyagi, T. J.K. Toung, J. R. Kirsch, R. J. Traystman, R. C. Koehler, P. D. Hurn, and A. Bhardwaj Neuroprotective {kappa}-Opioid Receptor Agonist BRL 52537 Attenuates Ischemia-Evoked Nitric Oxide Production In Vivo in Rats Stroke, June 1, 2003; 34(6): 1533 - 1538. [Abstract] [Full Text] [PDF]